Basel Medical Group Ltd Ordinary Shares Long Term Debt

As of the most recent data (June 2026), BMGL shows a long-term debt of $3.4M. That compares with $1.3M in the prior-year period — up 161.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMGL's long-term debt is now $3.4M (was $1.3M) — a 161.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Basel Medical Group Ltd Ordinary Shares is outperforming or lagging.

Tracking BMGL's long-term debt over time shows whether Basel Medical Group Ltd Ordinary Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $3.4M That compares with $1.3M in the prior-year period — up 161.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Basel Medical Group Ltd Ordinary Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $3.4M) with ownership activity and broader fundamentals.